Page last updated: 2024-08-24

fluorodeoxyglucose f18 and rifamycins

fluorodeoxyglucose f18 has been researched along with rifamycins in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, YC; Franquet, E; Gifford, AE; Joyce, RM; Kolodny, GM; Moss, AC; Palmer, MR; Sedora-Roman, N; Selen, DJ	1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and rifamycins

Article	Year
Rifaximin suppresses background intestinal 18F-FDG uptake on PET/CT scans. Nuclear medicine communications, 2014, Volume: 35, Issue:10 Topics: Adult; Anti-Bacterial Agents; Cecum; Cohort Studies; Colon; Drug Interactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intestinal Mucosa; Intestines; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rifamycins; Rifaximin	2014

Article

Year

Rifaximin suppresses background intestinal 18F-FDG uptake on PET/CT scans.

Nuclear medicine communications, 2014, Volume: 35, Issue:10

Topics: Adult; Anti-Bacterial Agents; Cecum; Cohort Studies; Colon; Drug Interactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intestinal Mucosa; Intestines; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rifamycins; Rifaximin

2014